Patent details

Basic Information

Publication number:

EP2894231

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151515814

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Responsiveness to angiogenesis inhibitors

French Title of Invention:

Sensibilité aux inhibiteurs de l'angiogenèse

German Title of Invention:

Ansprechempfindlichkeit auf Angiogenesehemmer

SPC Number:

Dates

Filing date:

03/08/2010

Grant date:

04/01/2017

EP Publication Date:

04/01/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/07/2015

EP B1 Publication Date:

04/01/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/08/2017

Expiration date:

03/08/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/08/2010

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Name:

Life Sciences Research Partners VZW

Address:

Campus Gasthuisberg Herestraat 49, bus 913, 3000 Leuven, Belgium (BE)

Name:

VIB vzw

Address:

Rijvisschestraat 120, 9052 Gent, Belgium (BE)

Inventor

1

Name:

Scherer Stefan

Address:

Switzerland (CH)

2

Name:

Lambrechts Diether

Address:

Belgium (BE)

3

Name:

Foernzler Dorothee

Address:

Switzerland (CH)

4

Name:

Delmar Paul

Address:

Switzerland (CH)

5

Name:

Carmeliet Peter

Address:

Belgium (BE)

Priority

Priority Number:

09167184

Priority Date:

04/08/2009

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C12Q 1/68;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages